Treg cell‐targeted therapy exerted an anticancer effect in mice bearing CIRT+HCQ‐treated tumors but not in those bearing untreated pancreatic tumors by activating cancer‐specific CD8+ T cells. The gene discussed is CD8A; the disease is pancreatic neoplasm.